Scopio Labs secured $50M in series C funding, which the company will use to scale manufacturing of its FDA-cleared imaging and AI analysis platform to support the shift to fully telehematology.
Scopio Labs secured $50M in series C funding, which the company will use to scale manufacturing of its FDA-cleared imaging and AI analysis platform to support the shift to fully telehematology.
Copyright © 2024 | WordPress Theme by MH Themes
